Jane Street’s Allarity Therapeutics ALLR Stock Holding History

Jane Street’s Portfolio ALLR Stock Details ALLR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-36,021	Closed	-$46.5K	–	11534
2026 Q2	$46.5K	Buy	+36,021	New	+$51.1K	﹤0.01%	10966
2025 Q3	–	Sell	-26,365	Closed	-$26.6K	–	10692
2025 Q2	$26.6K	Buy	+26,365	New	+$24.9K	﹤0.01%	9313
2024 Q3	–	Sell	-522	Closed	-$3.34K	–	9510
2024 Q2	$3.34K	Buy	+522	New	+$20.5K	﹤0.01%	9180

Other funds holding ALLR

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $96.6B AUM 22.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Jane Street's ALLR Position: Q3 2026 in Review

Jane Street sold out of Allarity Therapeutics (ALLR) in Q3 2026, closing a stake of 36,021 shares — an estimated $46.5K sold.

Jane Street first reported a position in ALLR in Q2 2024 and held it in 3 quarters. The position peaked at $46.5K in Q2 2026. 11 funds tracked by Wall St. Rank hold ALLR as of Q3 2026.

Jane Street reported no remaining Allarity Therapeutics position as of Q3 2026 after selling out during the quarter.
Jane Street sold 36,021 Allarity Therapeutics shares in Q3 2026, an estimated $46.5K.
Jane Street first reported a position in Allarity Therapeutics in Q2 2024 and held it in 3 quarters.
Jane Street's Allarity Therapeutics position peaked at $46.5K in Q2 2026.
11 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.